Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part II: Recommendations for microbiological diagnosis in cystic fibrosis

Rev Med Chir Soc Med Nat Iasi. Jul-Sep 2012;116(3):898-901.

Abstract

Current standards of sputum examination in respiratory infections with opportunistic bacteria cannot be applied to patients with cystic fibrosis due to their particularities. In 2010, a working group from Great Britain established standards for microbiological processing of samples from patients with cystic fibrosis. Recommendations on sample collection, transportation, storage, and processing, identification of bacterial isolates and in vitro antibiotic susceptibility are made. Also recommended is that the multidisciplinary team monitoring patients with cystic fibrosis to include a microbiologist.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / isolation & purification*
  • Cystic Fibrosis / drug therapy
  • Cystic Fibrosis / microbiology*
  • Humans
  • Interdisciplinary Communication
  • Microbial Sensitivity Tests / methods
  • Monitoring, Physiologic
  • Practice Guidelines as Topic
  • Respiratory Tract Infections / drug therapy
  • Respiratory Tract Infections / microbiology*
  • Romania
  • Specimen Handling
  • Sputum / microbiology

Substances

  • Anti-Bacterial Agents